Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

Fall of
-0.76 (-0.93%%) SANOFI - [Ticker: SAN.PA]Chart SANOFI  News SANOFI  Download Historical Prices for Metastock SANOFI and Others  Technical Analysis SANOFI  
Last Trade80.53Last Trade Time2017-11-01 - 21:36:00
Variation-0.76 (-0.93%)Open81.79
Volume2,902,429Average Volume (3m)0
YieldBid / Ask71.12 x 1,000 - 71.74 x 44,000
Former Close81.2952 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
SANOFI -  [Ticker: SAN.PA] chart
Change to SANOFI Interactive Technical Analysis Chart

Last 10 Forum Topics about SANOFI:
No topics about SANOFI [SAN.PA] have been found, but a search on the Forum for more topics related to SANOFI is advised.

 News about SANOFI [SAN.PA]:   (ordered by relevance)
Seagen goes to Pfizer for $43B; Sanofi buys diabetes partner ...  Endpoints News Sanofi to cut US price of its most-prescribed insulin by 78%  Reuters Facing political pressure, Sanofi follows Eli Lilly and Novo Nordisk in slashing insulin prices  CNBC Another one! Sanofi joins growing list of insulin manufacturers to cap cost of life-saving drug  Daily Mail Sanofi to acquire Provention Bio in deal worth $2.9bn  PMLiVE Ipsen receives new palovarotene PDUFA date; Acer halts ...  Endpoints News Sanofi adds mRNA 2.0 to its vaccine toolkit  KBR Sanofi reports positive new data for multiple sclerosis treatment ...  PMLiVE Sanofi's site modernization spree rolls on with plan to shift 2000 ...  FiercePharma Sanofi and Sobi?s once-weekly haemophilia A treatment approved ...  PMLiVE Sanofi - Aventis Groupe Announcements | Sanofi - Aventis Groupe ...  InvestEgate Sanofi (SNY) Dips More Than Broader Markets: What You Should ...  Yahoo Finance Patent wars: What?s behind Amgen?s possible win over Sanofi at the ...  Pharmaceutical Technology Investors in Sanofi (EPA:SAN) have made a decent return of 66% over the past five years  Simply Wall St Sanofi Could Be on a Roll With a Strong Performance and Its Latest ...  The Motley Fool Lilly Slashed Its Insulin Prices. Will Sanofi and Novo Nordisk Do the ...  Managed Healthcare Executive The IIIs have it! Sanofi's fresh approval of bleeding drug Altuviiio ...  FiercePharma Bernie Sanders calls out Sanofi, Novo Nordisk for insulin prices  FiercePharma Glooko, Sanofi announce partnership to support diabetes patients  Medical Device Network Sanofi: Phase-3 study on Hemophilia A treatment met primary ...  Reuters Successful transaction: Adragos Pharma has officially taken over the ...  RealWire Regeneron, Sanofi's Kevzara nabs polymyalgia rheumatica FDA nod  FiercePharma Sanofi to discontinue Insuman® insulins over upcoming months Sanofi invests in successful Geisinger Commonwealth REACH-HEI ...  Geisinger Sanofi India declares ?194 final dividend and ?183 special dividend | Mint  Mint Shaheen, Collins Issue Joint Statement on Sanofi?s Decision to ...  Senator Jeanne Shaheen Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi  Yahoo Finance Rabies Vaccine Market Generated Opportunities, Future Scope ...  Digital Journal Morristown council breaks more Sanofi news, and questions ...  Morristown Green Sanofi, Regeneron launch new Dupixent asthma TV ad urging ...  FiercePharma Human Combination Vaccines Market Future Business ...  Digital Journal Sanofi Stock: Pharma Tees Up To Rival Pfizer In RSV Vaccine Battle ...  Investor's Business Daily Drug developer QurAlis raises $88 mln in Sanofi-backed funding ... Recon: FDA approves Sanofi's bleeding disorder drug; Sen. Warren ...  Regulatory Focus Sepsis - Pipeline Insight, 2022: Innovations from SciClone, Sanofi ... Sanofi sings a song for rare disease and equitable care  pharmaphorum Sanofi to bring two rare disease therapies to India  BusinessLine Mayor Touts M Station Addition As Sanofi Prepares For Morristown Move  Patch Sanofi plans to cut price of insulin, following Eli Lilly, Novo Nordisk public companies who own 60% along with institutions invested in Sanofi India Limited (NSE:SANOFI) saw increase in their holdings value last week  Simply Wall St CDSCO Panel grants Sanofi's Protocol Amendment Proposal for Quadrivalent Meningococcal Conjugate Vaccine  Medical Dialogues featured highlights Sanofi, SK Telecom, PBF Energy, Arrow Electronics and Novartis  Yahoo Finance Amgen Reply Brief Addresses Mischaracterizations by Sanofi, U.S. ... Despite Boston layoffs, business is booming: Resilience CEO  FiercePharma Sanofi (SNY), Regeneron Dupixent sBLA Accepted for FDA Review  Nasdaq Buy Sanofi India, target price Rs 6200: Sharekhan by BNP Paribas  The Economic Times Acer Therapeutics' Product Acquired From Sanofi Fails In Menopause Study - Acer Therapeutics (NASDAQ:ACER  Benzinga Global RNAi Therapeutics Market 2023 to 2027: Featuring Sanofi, Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma and Sirnaomics  Yahoo Finance Amgen v. Sanofi: Supreme Court to Hear Patent Enablement ...  Lexology A Look Into Sanofi's Debt - Sanofi (NASDAQ:SNY)  Benzinga Sanofi's Buscopan combines high fashion with IBS awareness at ...  MM+M Online Pfizer's maternal RSV vaccine filing gets priority review, setting up ...  FierceBiotech What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing? Lysosomal Storage Diseases Therapeutics Market Is Expected To ...  Digital Journal Dividend Stocks: These 2 companies announce 3900% dividend to shareholders  Zee Business North America Kidney Transplant Market Report 2023 - 2027 ... Global Endometriosis Market Report 2023: Featuring Teva, Sun ...  Yahoo Finance Sanofi?s enzyme replacement therapy available on NHS to Pompe ...  PMLiVE Sanofi Pasteur COVID-19 vaccine authorised by MHRA  GOV.UK GSK and Sanofi shares surge after Zantac ruling victory  Financial Times Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi ...  GOV.UK Sanofi trade union network building constructive relationship with ...  IndustriALL Global Union UK at risk of losing healthcare innovation race with European rivals ...  Financial Times Signed order Sanofi International Biotech Company Ltd.  GOV.UK Sanofi: The arrival of the 'haute couture' supply chain  Supply Chain Digital Decision on Sanofi Ltd  GOV.UK Sanofi announces change in R&D leadership  Science Business Sanofi and Innate Pharma expand cancer therapeutics collaboration  PMLiVE Is Sanofi's Stock Performance Being Led By Robust Fundamentals?  Simply Wall St Sanofi and Regeneron face a high-risk test for Dupixent Decision on Sanofi International Biotech Company Ltd.  GOV.UK Sanofi/Regeneron?s Dupixent approved by EC for eosinophilic ...  PMLiVE Sanofi CFO says stock price pummelling grossly overdone  Reuters Exclusive: Sanofi to let go of staff at vaccine plants in India as part of ... Sanofi started?and lost?$28B bidding war for Horizon. Is the ...  FiercePharma Big Pharma divided? Pfizer, AZ, Lilly and more support Sanofi in ...  FiercePharma Sanofi pulls phase 3 trial of $3.7B drug as competition heats up  FierceBiotech JPM23: Sanofi has reached the 'steady state' Paul Hudson ...  FiercePharma Sanofi offers refunds for Cablivi in novel model for rebates  Pharmaceutical Technology Sanofi/ Regeneron?s Dupixent recommended by CHMP to treat ...  PMLiVE Sanofi forecasts moderate profit growth on Dupixent demand  Reuters Sanofi enlists Thread as decentralised clinical trial provider in new ...  Clinical Trials Arena AstraZeneca, Sanofi tee up 3-way RSV battle in 2023 as FDA ...  FiercePharma Surprise, Skepticism And Scorn: Reaction To Rumored Haleon ...  HBW Insight GSK, Sanofi, Takeda sign with Singapore partnership to advance ...  FiercePharma Bruised by high profile cancer setbacks, Sanofi CEO plots early ...  FierceBiotech GSK takes a cue from Sanofi with plans for a new headquarters  FiercePharma Sanofi and Regeneron?s Dupixent granted EC approval for prurigo ...  PMLiVE Sanofi to sell Japanese manufacturing plant  European Pharmaceutical Review Amgen, J&J and Sanofi size up Horizon as Big Pharma renews ...  FiercePharma Euro Q4 Consumer Health Earnings Preview: Sanofi, Bayer, Reckitt ...  HBW Insight Sanofi seeks to launch blood disorder drug this year, CNBC reports  Reuters Sanofi picks Thread as sole provider of decentralized clinical trials ... Sanofi's (EPA:SAN) 6.3% CAGR outpaced the company's earnings growth over the same five-year period  Simply Wall St Sanofi, Boehringer expect answers in Zantac dispute this year  FiercePharma Sanofi's market cap is in free fall, but the reaction is 'overdone ...  FiercePharma Is Sanofi A Buy, Despite Recent Stumbles?  Entrepreneur J&J bows out of Horizon bid as Sanofi and Amgen eye cash plays  FiercePharma Sanofi and GSK?s next-generation COVID-19 booster vaccine ...  GSK
For more news about SANOFI click here:
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2023 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources